The effects of coenzyme Q10(CoQ10) on exercise performance were studied in 12 patients, average age 56 years, with stable angina pectoris. The study involved a double-blind, placebo-controlled, randomized, crossover protocol, using multistage treadmill exercise tests. CoQ10(150 mg/day in 3 daily doses) was administered orally for 4 weeks, tended to reduce anginal frequency from 5.3 +/- 4.9 to 2.5 +/- 3.3 attacks for 2 weeks and nitroglycerin consumption from 2.6 +/- 2.8 to 1.3 +/- 1.7 tablets for 2 weeks compared with patients receiving the placebo, but the reduction was not statistically significant. Exercise time increased from 345 +/- 102 seconds with placebo to 406 +/- 114 seconds during CoQ10 treatment (p less than 0.05). The time until 1 mm of ST-segment depression occurred increased from 196 +/- 76 seconds with placebo to 284 +/- 104 seconds during CoQ10 treatment (p less than 0.01). During the exercise test, ST-segment depression, heart rate and pressure-rate product at the same and at the maximal workload showed no significant difference between patients after placebo and CoQ10 administration. The average CoQ10 plasma concentration increased from 0.95 +/- 0.48 microgram/ml to 2.20 +/- 0.98 microgram/ml after CoQ10 treatment. This increase was significantly related to the increase in exercise duration (r = 0.68, p less than 0.001). Only 1 patient had a loss of appetite, but continued therapy. This study suggests that CoQ10 is a safe and promising treatment for angina pectoris.
Clinical Trial The American journal of cardiology. 1985 Aug 1;56(4):247-51. doi: 10.1016/0002-9149(85)90843-4 Q32.32024
Effects of coenzyme Q10 on exercise tolerance in chronic stable angina pectoris
辅酶Q10对慢性稳定型心绞痛运动耐力的影响 翻译改进
作者单位 +展开
作者单位
DOI: 10.1016/0002-9149(85)90843-4 PMID: 3927692
摘要 Ai翻译
Keywords：coenzyme Q10
关键词：辅酶Q10
相关内容
-
Biopharmaceutical characterization of nanocrystalline solid dispersion of coenzyme Q10 prepared with cold wet-milling system
用于CoQ10纳米结晶固体分散体制备的冷湿磨系统的生物制药表征研究
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. 2014 Mar 12:53:118-25.
-
[Coenzyme Q10 and alpha-tocopherol in patients after heart transplantation]
[心脏移植患者血浆辅酶Q10和α-生育酚水平]
Bratislavske lekarske listy. 1996 Oct;97(10):603-6.
-
Effect of coenzyme-q10 on Doxorubicin-induced nephrotoxicity in rats
辅酶Q10对阿霉素致大鼠肾毒性的保护作用研究
Advances in pharmacological sciences. 2012:2012:981461.
-
Coenzyme Q10 protects against hyperlipidemia-induced cardiac damage in apolipoprotein E-deficient mice
辅酶Q10可保护载脂蛋白E缺乏型小鼠向高血压转变所致的心脏损害
Lipids in health and disease. 2018 Dec 8;17(1):279.
-
Coenzyme Q10
辅酶Q10
Alternative medicine review : a journal of clinical therapeutic. 1998 Feb;3(1):58-61.
-
Protection by coenzyme Q10 from myocardial reperfusion injury during coronary artery bypass grafting
辅酶Q10对冠状动脉旁路移植术中再灌注损伤的保护作用
The Annals of thoracic surgery. 1994 Nov;58(5):1427-32.
-
[Application of orthogonal function spectrophotometry to the determination of the coenzyme Q10 content in the injection]
正交函数光度法测定辅酶Q10注射液中辅酶Q10的含量
Yao xue xue bao = Acta pharmaceutica Sinica. 1985 Feb;20(2):118-22.
-
Prevention of contrast induced-acute kidney injury using coenzyme Q10 in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
辅酶Q10预防ST段抬高型心肌梗死患者行直接经皮冠状动脉介入术的对比剂致急性肾损伤风险
European journal of clinical pharmacology. 2023 Oct;79(10):1341-1356.
